Second, we applied a series of sensitivity analyses and set a Bonferroni-corrected threshold for multiple testing, followed by colocalization analyses, to boost the reliability and robustness of the results
If you miss a dose and it has been more than 3 days, do not take the dose
In terms of weight loss at comparable time points, tirzepatide consistently outperforms semaglutide in clinical trials
Long-term safety data continues to accumulate, and a comprehensive 2024 review in Diabetes Care by Daniel Drucker concluded that the overall risk-benefit profile of GLP-1 medicines remains favorable for their approved indications
What youll learn: High costs and uncomfortable side effects of traditional GLP-1 medications lead many people to stop using them
Focus on fresh, minimally processed foods